Back to Home
Free CE/CMEVideo

Live Tumor Board: Multidisciplinary Strategies to Prevent and Manage ADC-Associated Pulmonary Toxicities in Ovarian Cancer

Release Date

April 21, 2026

Expiration Date

May 27, 2026

Credits

1.25 CME, NCPD

Specialties

Gynecologic Cancer, New Drugs+3 more

Activity Overview

This educational activity is an archive of the live presentation held on April 11, 2026.

For more information about this educational activity, the faculty, and disclosures, please click here.

Target Audience

This educational activity is directed toward attendees of the Society of Gynecologic Oncology Annual Meeting on Women’s Cancer; these include gynecologic oncologists, medical oncologists, advanced practice providers, nurses, pulmonologists, radiologists, and other health care providers involved in the management of patients with ovarian cancer.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Describe strategies to assess baseline pulmonary function, and select appropriate candidates for ADC therapy in ovarian cancer
  • Develop practical monitoring and triage approaches for early detection of ADC-related pulmonary toxicities in patients with ovarian cancer
  • Apply evidence-informed, grade-based algorithms for the evaluation, treatment, and follow-up of ADC-related ILD and pneumonitis in patients with ovarian cancer
  • Implement multidisciplinary care pathways that engage oncology, pulmonology, radiology, and nursing or advanced practitioners to optimize coordination of care
Live Tumor Board: Multidisciplinary Strategies to Prevent and Manage ADC-Associated Pulmonary Toxicities in Ovarian Cancer

GET STARTED WITH THIS PROGRAM:

Register now to gain access to this program.

Create AccountAlready Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.25 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from AbbVie, Inc.

Follow Us on Social Media!

Related Content

Course

Live Tumor Board: Multidisciplinary Strategies to Prevent and Manage ADC-Associated Pulmonary Toxicities in Ovarian Cancer

Create Account